SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Valion Bio and Shear Kershman Labs formulate oral mucosal Entolimod

Valion Bio reports that it and Shear Kershman Laboratories successfully formulated oral mucosal Entolimod. The company says it sees potential for multi-fold expansion of its long-term opportunity.

VBIO